Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rodger

Showing results (171-180 of 295) with videos related to

Pageof 30
Sort By:
Biopolymers|September 19, 1998
Spectroscopic studies of 9-hydroxyellipticine binding to DNAM A Ismail, K J Sanders, G C Fennell, et al.
British Journal of Cancer|May 1, 1992
Locally advanced breast cancer: report of phase II study and subsequent phase III trialA Rodger, W J Jack, P D Hardman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 7, 2012
Tinzaparin versus dalteparin for periprocedure prophylaxis of thromboembolic events in hemodialysis patients: a randomized trialMarc A Rodger, Tim Ramsay, Martin MacKinnon, et al.
Thrombosis Research|March 12, 2004
The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapyMarc A Rodger, Christine Gagné-Rodger, Heather E Howley, et al.
Thrombosis Research|November 14, 2006
The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysisMarc Carrier, Greg A Knoll, Michael J Kovacs, et al.
Chest|July 14, 2001
Steady-state end-tidal alveolar dead space fraction and D-dimer: bedside tests to exclude pulmonary embolismM A Rodger, G Jones, P Rasuli, et al.
BMC Medical Research Methodology|January 12, 2012
Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysisAlejandro Lazo-Langner, Marc A Rodger, Nicholas J Barrowman, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2006
The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?Philip S Wells, Josdalyne L Anderson, Marc A Rodger, et al.
British Journal of Cancer|May 1, 1992
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone diseaseR E Coleman, S Houston, I James, et al.
Systematic Reviews|October 30, 2019
Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocolFaizan Khan, Miriam Kimpton, Tobias Tritschler, et al.
Pageof 30

Showing results (171-180 of 295) with videos related to

Sort By:
Pageof 30
Biopolymers|September 19, 1998
Spectroscopic studies of 9-hydroxyellipticine binding to DNAM A Ismail, K J Sanders, G C Fennell, et al.
British Journal of Cancer|May 1, 1992
Locally advanced breast cancer: report of phase II study and subsequent phase III trialA Rodger, W J Jack, P D Hardman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 7, 2012
Tinzaparin versus dalteparin for periprocedure prophylaxis of thromboembolic events in hemodialysis patients: a randomized trialMarc A Rodger, Tim Ramsay, Martin MacKinnon, et al.
Thrombosis Research|March 12, 2004
The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapyMarc A Rodger, Christine Gagné-Rodger, Heather E Howley, et al.
Thrombosis Research|November 14, 2006
The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysisMarc Carrier, Greg A Knoll, Michael J Kovacs, et al.
Chest|July 14, 2001
Steady-state end-tidal alveolar dead space fraction and D-dimer: bedside tests to exclude pulmonary embolismM A Rodger, G Jones, P Rasuli, et al.
BMC Medical Research Methodology|January 12, 2012
Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysisAlejandro Lazo-Langner, Marc A Rodger, Nicholas J Barrowman, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2006
The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?Philip S Wells, Josdalyne L Anderson, Marc A Rodger, et al.
British Journal of Cancer|May 1, 1992
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone diseaseR E Coleman, S Houston, I James, et al.
Systematic Reviews|October 30, 2019
Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocolFaizan Khan, Miriam Kimpton, Tobias Tritschler, et al.
Pageof 30